
Sigli 2mg Tablet
Marketer
Siomond Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg)
Overview Sigli 2mg Tablet
Diabetac 2mg tablets, a sulfonylurea, manage type 2 diabetes in adults by regulating blood glucose, thus mitigating complications like vision impairment and kidney failure. This medication can be prescribed alone or in conjunction with other therapies. Administer it immediately before or with your first meal daily, consistently at the same time for optimal results. Dosage is determined by your physician and may adjust based on your glucose readings. Continuous use is crucial; discontinuation without medical guidance may lead to elevated blood sugar and increased risk of diabetic complications, including neuropathy, limb loss, and the aforementioned vision and kidney issues. Remember, Diabetac 2mg tablets are part of a comprehensive approach involving diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices are integral to diabetes control. Common adverse effects include hypoglycemia (low blood sugar), nausea, cephalalgia (headache), asthenia (weakness), and vertigo (dizziness). Learn to identify hypoglycemia symptoms (sweating, dizziness, headache, tremors) and manage them appropriately. Maintain regular mealtimes and carry readily available glucose, such as sugary snacks or juice. Alcohol consumption should be limited due to increased hypoglycemia risk. Weight gain is a possible side effect. Diabetac 2mg tablets are contraindicated in type 1 diabetes, diabetic ketoacidosis, and significant liver or kidney dysfunction. Inform your doctor of any pre-existing heart, thyroid, or endocrine disorders before commencing treatment, as it may not be appropriate. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential; additional blood tests for hematological and hepatic function may also be recommended.
Primary Ingredients of Sigli 2mg Tablet
The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.
Uses of Sigli 2mg Tablet
Managing Type 2 diabetes
Major Benefits of Sigli 2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 2mg Sigli tablet should be administered with a meal.
Common Side effects of Sigli 2mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Sigli 2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 2mg Sigli tablet should be taken with a meal.
How Sigli 2mg Tablet works:
Pancreatic insulin release is stimulated by the antidiabetic drug, Sigli 2mg Tablet, thus reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sigli 2mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sigli 2mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Sigli 2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of the nursing infant's blood glucose levels is recommended when the mother takes Sigli 2mg tablets.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Caution is advised when prescribing Sigli 2mg Tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Sigli 2mg Tablets are contraindicated in patients with severe kidney disease due to the risk of pronounced hypoglycemia, which may resolve gradually.
LiverCAUTION
Caution is advised when prescribing Sigli 2mg Tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. Sigli 2mg Tablets are contraindicated in patients exhibiting severe liver disease due to the risk of significant hypoglycemia, which may resolve only after an extended period.
What if you forget to take Sigli 2mg Tablet :
Omit the missed Sigli 2mg Tablet dose and resume your regular dosing schedule.
Facts to Know About Sigli 2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Advanced Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
